Quick Answer
Edwards Lifesciences Corp reported Diluted EPS of $1.83 per share for fiscal year 2025.
Edwards Lifesciences Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $1.83 | -73.7% |
| 2024 | $6.97 | +203.0% |
| 2023 | $2.30 | -5.7% |
| 2022 | $2.44 | +2.5% |
| 2021 | $2.38 | +83.1% |
| 2020 | $1.30 | -20.7% |
| 2019 | $1.64 | +45.1% |
| 2018 | $1.13 | -58.1% |
| 2017 | $2.70 | +3.4% |
| 2016 | $2.61 | +16.0% |
| 2015 | $2.25 | -39.8% |
| 2014 | $3.74 | +118.7% |
| 2013 | $1.71 | -30.5% |
| 2012 | $2.46 | +24.2% |
| 2011 | $1.98 | +8.2% |
| 2010 | $1.83 | -6.2% |
| 2009 | $1.95 | +77.3% |
| 2008 | $1.10 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.50 | -90.3% | -10.7% |
| June 30, 2025 | $0.56 | -8.2% | -8.2% |
| March 31, 2025 | $0.61 | +5.2% | -88.1% |
| September 30, 2024 | $5.13 | +714.3% | +741.0% |
| June 30, 2024 | $0.61 | +22.0% | +5.2% |
| March 31, 2024 | $0.58 | +3.6% | -7.9% |
| September 30, 2023 | $0.63 | +14.5% | +26.0% |
| June 30, 2023 | $0.50 | -23.1% | -10.7% |
- Edwards Lifesciences Corp showed a decrease of -73.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2008–2025 period, Edwards Lifesciences Corp’s diluted eps has grown by 66.4% (from $1.10 per share to $1.83 per share).
- The most recent figure is from Edwards Lifesciences Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: